Varumärket MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease, grundat 2013 (United States), från 126 systervarumärken och 17478 konkurrerande varumärken. Varumärket MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease ägs av Celgene, ett företag som är börsnoterat i New York. MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease tillhör näringsgrenen Läkemedelstillverkare.

MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease är ett varumärke som tillhör Celgene () Andra varumärken

Köp Celgene-aktier med

(0 % provision och delandelar)

Ditt kapital är i riskzonen. Andra avgifter tillkommer. För mer information, besök etoro.com/trading/fees.

Andra varumärken
Celgene

JUNO THERAPEUTICS

A
- APICES
- AMDAC
- ACELAGRAFT
- ANTHROGENESIS
- ACSELA
- ARTIMIDS
- APACT
- ADVANCING IMID SCIENCE
- APR
B
- BIOVANCE
- BECLIPSA
- BODAPRA
C
- COMPROMISO 360
- CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE (CITRE)
- CELGENE THALIDOMIDE
- C2ARE
- CELGENE i-access
- CELGENECARE
- CANCERCAN
- cintre
- CONTINUUM
- CELG
- CHIMERIC VIGOR
- CELMOD
- CELGENE MULTIPLE MYELOMA RESOURCE CENTER
- CELGENE AVILOMICS RESEARCH
- CELGENE MATRIX
- CYTUNE
- CITRE
- CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE
- CANCER
- CELGENE COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
D
- DOING WELL BY DOING GOOD
- DIRAZEC
E
- EXPECT
- EGARZO
- EMCRUZO
- ENKEPLO
- EJETSA
- ESTEEM
F
- FIDHIRO
- FOCUSING ON THOSE WHO CAN LEAST AFFORD TO LIVE
- FIRST TRIAL
G
- GLOBAL PSORIASIS SURVEY Navigating the Course of Psoriatic Disease
H
- HUMANIFESTO
I
- IACCESS
- ISELATE
- IMID
- IDHISO
- INREBIC
- IMLINIR
- IMNOVYD
- IMNOVID
- ISTODAX
- IMLINEER
K
- KEXTENA
- KEVOLI
L
- LifebankUSA
M
- MULTIPLE PATHWAYS, MULTIPLE TARGETS
- MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
- MYELOMA ALLY
- MM 013
- MATRIX Medical Affairs Tracking Reporting and Information Xchange
- MATRIX: MEDICAL AFFAIRS TRACKING REPORT AND INFORMATION XCHANGE
- MAINSAIL
- mpact
N
- NIMBUS
O
- ORIGIN
- ORVIMID
- ONUREG
- OKEZLI
- ONCRUZO
- OTEZLA
- OCRUZO
- OGARTEZ
- ORCOMPAS
- OPTIMISMM
- ODAPRA
P
- PEBIOR
- PRIORITY MEDICINE. IN PRACTICE.
- PHARMION
- PURARIT
- POSTURE
- POMALISS
- POMALYST
- PAZNEO
- POMD
- POML
- PALACE
Q
- QUAZAR
R
- REVAID
- RevAssist
- Rev
- Revlimid
- RIMIDRA
- RULOYUS
- RAPVOTI
- ROJUSNA
- REBLOZEL
- ROJUZDA
- RYORLO
- ROBUST
- RELEVANCE
- RELEVANT
- RESUME
S
- sprint
- SECLIPSA
- SOSTEGRA
- S.T.E.P.S.
- SELARREST
- SELATAK
- SUVMIDI
T
- THALIDOMIDE CELGENE
- TURNING CANCER INTO CAN
- TREATMENT CONTINUATION SCHEME
- TCS
- TIME IN A CAPSULE
- THALOMID
- TNACITY
- TIME TO LIVE
- THALIDOMIDE PHARMION
V
- VIPP
- Vidaza
- VOLOMYD